Table 1.
Demographic Data of 602 Participants, Including Diabetics and Nondiabetics
| Total (N = 602) | Diabetics (N = 252, 41.9%) | Nondiabetics (N = 350, 58.1%) | P‐value | |
|---|---|---|---|---|
| Age, years | 62.1 ± 13.4 | 64.7 ± 10.8 | 60.3 ± 14.7 | <0.0001 |
| Gender, men (%) | 60 | 61.5 | 58.9 | 0.5126 |
| Body mass index, kg/m2 | 25.6 ± 3.8 | 26.6 ± 3.6 | 24.9 ± 3.8 | <0.0001 |
| Hypertension (%) | 88.9 | 95.6 | 84 | <0.0001 |
| Hyperuricemia (%) | 32.1 | 27.4 | 35.4 | 0.0369 |
| Hyperlipidemia (%) | 66.3 | 73 | 61.4 | 0.0030 |
| Serum creatinine, mg/dL | 2.2 ± 1.9 | 2.2 ± 1.8 | 2.2 ± 2.0 | 0.7530 |
| eGFR, ml/min/1.73 m2 (MDRD) | 45.9 ± 28.6 | 43.8 ± 26.8 | 47.4 ± 29.8 | 0.1260 |
| UACR, mg/g | 189 (35–806) | 309 (57–1,286) | 140 (26–564) | <0.0001 |
| UPCR, mg/g | 376 (120–1,256) | 583 (157–2,161) | 311 (94–994) | <0.0001 |
| UAPR | 0.49 ± 0.22 | 0.51 ± 0.20 | 0.46 ± 0.23 | 0.0050 |
| Glycated hemoglobin, % | 7.3 ± 1.5 | |||
| CKD stage 1 and 2 (%) | 28.58 | 27 | 29.7 | 0.5610 |
| CKD stage 3 (%) | 37.38 | 36.5 | 38 | |
| CKD stage 4 (%) | 18.44 | 21 | 16.6 | |
| CKD stage 5 (%) | 15.61 | 15.5 | 15.7 |
Age, body mass index, serum creatinine, eGFR, UAPR, and glycated hemoglobin are expressed as mean ± standard deviations.
Gender, hypertension, diabetes, hyperuricemia, and hyperlipidemia are expressed as percentage.
UACR and UPCR are expressed as median with interquartile range.
eGFR, estimated glomerular filtration rate; MDRD, Modification of Diet in Renal Disease study; UACR, urine albumin to creatinine ratio; UPCR, urine total protein to creatinine ratio; UAPR, urine albumin to total protein ratio; CKD, chronic kidney disease.
P‐value indicates the significance of difference between diabetics and nondiabetics.